Cargando…
Epigallocatechin-3-gallate (EGCG) inhibits the migratory behavior of tumor bronchial epithelial cells
BACKGROUND: Many studies associated the main polyphenolic constituent of green tea, (-)-Epigallocatechin-3-gallate (EGCG), with inhibition of cancers, invasion and metastasis. To date, most of the studies have focused on the effect of EGCG on cell proliferation or death. Since cell migration is an i...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362119/ https://www.ncbi.nlm.nih.gov/pubmed/18426555 http://dx.doi.org/10.1186/1465-9921-9-33 |
_version_ | 1782153381900451840 |
---|---|
author | Hazgui, Salma Bonnomet, Arnaud Nawrocki-Raby, Béatrice Milliot, Magali Terryn, Christine Cutrona, Jérôme Polette, Myriam Birembaut, Philippe Zahm, Jean-Marie |
author_facet | Hazgui, Salma Bonnomet, Arnaud Nawrocki-Raby, Béatrice Milliot, Magali Terryn, Christine Cutrona, Jérôme Polette, Myriam Birembaut, Philippe Zahm, Jean-Marie |
author_sort | Hazgui, Salma |
collection | PubMed |
description | BACKGROUND: Many studies associated the main polyphenolic constituent of green tea, (-)-Epigallocatechin-3-gallate (EGCG), with inhibition of cancers, invasion and metastasis. To date, most of the studies have focused on the effect of EGCG on cell proliferation or death. Since cell migration is an important mechanism involved in tumor invasion, the aim of the present work was to target another approach of the therapeutic effect of EGCG, by investigating its effect on the cell migratory behavior. METHODS: The effect of EGCG (at concentrations lower than 10 μg/ml) on the migration speed of invasive cells was assessed by using 2D and 3D models of cell culture. We also studied the effects of EGCG on proteinases expression by RT-PCR analysis. By immunocytochemistry, we analyzed alterations of vimentin organization in presence of different concentrations of EGCG. RESULTS: We observed that EGCG had an inhibitory effect of cell migration in 2D and 3D cell culture models. EGCG also inhibited MMP-2 mRNA and protein expression and altered the intermediate filaments of vimentin. CONCLUSION: Taken together, our results demonstrate that EGCG is able to inhibit the migration of bronchial tumor cells and could therefore be an attractive candidate to treat tumor invasion and cell migration. |
format | Text |
id | pubmed-2362119 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-23621192008-04-30 Epigallocatechin-3-gallate (EGCG) inhibits the migratory behavior of tumor bronchial epithelial cells Hazgui, Salma Bonnomet, Arnaud Nawrocki-Raby, Béatrice Milliot, Magali Terryn, Christine Cutrona, Jérôme Polette, Myriam Birembaut, Philippe Zahm, Jean-Marie Respir Res Research BACKGROUND: Many studies associated the main polyphenolic constituent of green tea, (-)-Epigallocatechin-3-gallate (EGCG), with inhibition of cancers, invasion and metastasis. To date, most of the studies have focused on the effect of EGCG on cell proliferation or death. Since cell migration is an important mechanism involved in tumor invasion, the aim of the present work was to target another approach of the therapeutic effect of EGCG, by investigating its effect on the cell migratory behavior. METHODS: The effect of EGCG (at concentrations lower than 10 μg/ml) on the migration speed of invasive cells was assessed by using 2D and 3D models of cell culture. We also studied the effects of EGCG on proteinases expression by RT-PCR analysis. By immunocytochemistry, we analyzed alterations of vimentin organization in presence of different concentrations of EGCG. RESULTS: We observed that EGCG had an inhibitory effect of cell migration in 2D and 3D cell culture models. EGCG also inhibited MMP-2 mRNA and protein expression and altered the intermediate filaments of vimentin. CONCLUSION: Taken together, our results demonstrate that EGCG is able to inhibit the migration of bronchial tumor cells and could therefore be an attractive candidate to treat tumor invasion and cell migration. BioMed Central 2008 2008-04-21 /pmc/articles/PMC2362119/ /pubmed/18426555 http://dx.doi.org/10.1186/1465-9921-9-33 Text en Copyright © 2008 Hazgui et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Hazgui, Salma Bonnomet, Arnaud Nawrocki-Raby, Béatrice Milliot, Magali Terryn, Christine Cutrona, Jérôme Polette, Myriam Birembaut, Philippe Zahm, Jean-Marie Epigallocatechin-3-gallate (EGCG) inhibits the migratory behavior of tumor bronchial epithelial cells |
title | Epigallocatechin-3-gallate (EGCG) inhibits the migratory behavior of tumor bronchial epithelial cells |
title_full | Epigallocatechin-3-gallate (EGCG) inhibits the migratory behavior of tumor bronchial epithelial cells |
title_fullStr | Epigallocatechin-3-gallate (EGCG) inhibits the migratory behavior of tumor bronchial epithelial cells |
title_full_unstemmed | Epigallocatechin-3-gallate (EGCG) inhibits the migratory behavior of tumor bronchial epithelial cells |
title_short | Epigallocatechin-3-gallate (EGCG) inhibits the migratory behavior of tumor bronchial epithelial cells |
title_sort | epigallocatechin-3-gallate (egcg) inhibits the migratory behavior of tumor bronchial epithelial cells |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362119/ https://www.ncbi.nlm.nih.gov/pubmed/18426555 http://dx.doi.org/10.1186/1465-9921-9-33 |
work_keys_str_mv | AT hazguisalma epigallocatechin3gallateegcginhibitsthemigratorybehavioroftumorbronchialepithelialcells AT bonnometarnaud epigallocatechin3gallateegcginhibitsthemigratorybehavioroftumorbronchialepithelialcells AT nawrockirabybeatrice epigallocatechin3gallateegcginhibitsthemigratorybehavioroftumorbronchialepithelialcells AT milliotmagali epigallocatechin3gallateegcginhibitsthemigratorybehavioroftumorbronchialepithelialcells AT terrynchristine epigallocatechin3gallateegcginhibitsthemigratorybehavioroftumorbronchialepithelialcells AT cutronajerome epigallocatechin3gallateegcginhibitsthemigratorybehavioroftumorbronchialepithelialcells AT polettemyriam epigallocatechin3gallateegcginhibitsthemigratorybehavioroftumorbronchialepithelialcells AT birembautphilippe epigallocatechin3gallateegcginhibitsthemigratorybehavioroftumorbronchialepithelialcells AT zahmjeanmarie epigallocatechin3gallateegcginhibitsthemigratorybehavioroftumorbronchialepithelialcells |